文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

六度分隔:增敏剂发展中的氧效应。

Six degrees of separation: the oxygen effect in the development of radiosensitizers.

机构信息

RadioRx, Inc, Mountain View, CA, USA.

出版信息

Transl Oncol. 2011 Aug;4(4):189-98. doi: 10.1593/tlo.11166. Epub 2011 Aug 1.


DOI:10.1593/tlo.11166
PMID:21804913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3140005/
Abstract

The popular theory six degrees of separation is used in this review as an analogy to relate all radiosensitization to oxygen. As the prime mover of all radiosensitizers, the pervasive influence of oxygen has consciously or unconsciously influenced the direction of research and development and provided the benchmark against which all other compounds and approaches are measured. It is the aim of this review to develop the six degrees of separation from oxygen analogy as a unifying framework for conceptually organizing the field and for giving context to its varied subspecializations and theories. Under such a framework, it would become possible for one area to consider questions and problems found in other areas of radiosensitization, using a common analogy, that would allow for further development and unification of this multifaceted discipline. In this review, approaches to the development of radiosensitizers and the current state of research in this field are discussed, including promising new agents in various stages of clinical development.

摘要

在这篇综述中,我们采用了六度分隔理论(six degrees of separation)这一流行理论来将所有的增敏作用与氧联系起来。作为所有增敏剂的主要驱动因素,无处不在的氧的影响有意或无意地影响了研究和开发的方向,并为所有其他化合物和方法提供了衡量基准。本综述旨在将六度分隔理论从氧的类比发展为一个统一的框架,用于从概念上组织该领域,并为其多样化的分支和理论提供背景。在这样的框架下,一个领域可以用一个共同的类比来考虑其他增敏领域的问题和挑战,从而促进这一多方面学科的进一步发展和统一。在本综述中,我们讨论了增敏剂的发展途径和该领域的研究现状,包括处于不同临床开发阶段的有前途的新药物。

相似文献

[1]
Six degrees of separation: the oxygen effect in the development of radiosensitizers.

Transl Oncol. 2011-8-1

[2]
Towards a Framework for Unifying Research in Theoretical Psychology.

Integr Psychol Behav Sci. 2024-12

[3]
The future of Cochrane Neonatal.

Early Hum Dev. 2020-11

[4]
The experimental and clinical rationale for the use of S-phase-specific radiosensitizers to overcome tumor cell repopulation.

Semin Oncol. 1992-8

[5]
Radiosensitizers, radioprotectors, and radiation mitigators.

Indian J Dent Res. 2014

[6]
[Radiosensitization research in cancer therapy].

Gan To Kagaku Ryoho. 1985-3

[7]
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements.

Adv Drug Deliv Rev. 2015-12-19

[8]
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy.

Int J Nanomedicine. 2020-11-24

[9]
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.

Neurooncol Pract. 2020-6

[10]
Chemical radiosensitization of hypoxic cells and redox potentials: correlation of voltammetric results with pulse radiolysis data of nitro-compounds and radiosensitizers.

Int J Radiat Biol Relat Stud Phys Chem Med. 1979-7

引用本文的文献

[1]
Substituted benzylamino-2'-deoxyadenosine a modified nucleoside with radiosensitizing properties.

Sci Rep. 2025-5-20

[2]
Exploring the molecular mechanism of cancer radiosensitization: the impact of physical stimulation therapy.

Strahlenther Onkol. 2025-3-11

[3]
Modeling of chemo-radiotherapy targeting growing vascular tumors: A continuum-level approach.

PLoS One. 2025-1-15

[4]
Golden era of radiosensitizers.

Front Vet Sci. 2024-12-6

[5]
Asymmetrically PEGylated and amphipathic heptamethine indocyanine dyes potentiate radiotherapy of renal cell carcinoma via mitochondrial targeting.

J Nanobiotechnology. 2024-12-18

[6]
STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses.

Natl Sci Rev. 2024-5-10

[7]
Inhibition of LNC EBLN3P Enhances Radiation-Induced Mitochondrial Damage in Lung Cancer Cells by Targeting the Keap1/Nrf2/HO-1 Axis.

Biology (Basel). 2023-9-4

[8]
Oxygen Imaging of a Rabbit Tumor Using a Human-Sized Pulse Electron Paramagnetic Resonance Imager.

Mol Imaging Biol. 2024-6

[9]
Innate Immune System in the Context of Radiation Therapy for Cancer.

Cancers (Basel). 2023-8-4

[10]
RRx-001: a chimeric triple action NLRP3 inhibitor, Nrf2 inducer, and nitric oxide superagonist.

Front Oncol. 2023-5-29

本文引用的文献

[1]
Dinitroazetidines are a novel class of anticancer agents and hypoxia-activated radiation sensitizers developed from highly energetic materials.

Cancer Res. 2012-5-15

[2]
Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer.

Cancer Sci. 2010-12-10

[3]
Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.

Nitric Oxide. 2010-10-8

[4]
Non-surgical care for locally advanced breast cancer: radiologically assessed therapeutic outcome of a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II) with systemic chemotherapy.

Oncol Rep. 2010-11

[5]
Proteomic analysis of lanthanum citrate-induced apoptosis in human cervical carcinoma SiHa cells.

Biometals. 2010-8-1

[6]
Pharmacokinetic/pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors.

Clin Cancer Res. 2010-8-20

[7]
Inhibitors of angiogenesis: new hopes for oncologists, new challenges for anesthesiologists.

Anesthesiology. 2010-9

[8]
Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.

Mol Cancer Ther. 2010-6-29

[9]
Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.

Blood. 2010-6-7

[10]
Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.

J Thorac Oncol. 2010-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索